Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $184.29 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences Inc | $113.55 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $47.32 | 1 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $23.42 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.42 | 1 | Siemens Medical Solutions USA, Inc. ($23.42) |
| 2017 | $160.87 | 2 | Gilead Sciences Inc ($113.55) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $23.42 | General |
| 06/04/2017 | Gilead Sciences Inc | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $113.55 | General |
| Category: HBV | ||||||
| 03/09/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $47.32 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 541 | 795 | $198,697 | $21,076 |
| 2022 | 10 | 557 | 820 | $193,840 | $24,385 |
| 2021 | 13 | 727 | 1,161 | $256,147 | $34,955 |
| 2020 | 13 | 602 | 950 | $211,523 | $30,091 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 168 | 218 | $59,732 | $5,753 | 9.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 41 | 161 | $30,268 | $3,416 | 11.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 154 | 160 | $26,240 | $3,111 | 11.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 43 | 59 | $22,833 | $2,854 | 12.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 21 | 36 | $28,872 | $2,224 | 7.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 48 | 54 | $10,152 | $1,412 | 13.9% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 11 | 23 | $9,154 | $1,069 | 11.7% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 14 | 26 | $5,616 | $691.82 | 12.3% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2023 | 11 | 27 | $3,753 | $439.70 | 11.7% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 30 | 31 | $2,077 | $104.78 | 5.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 190 | 258 | $64,242 | $7,067 | 11.0% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 56 | 76 | $26,752 | $4,058 | 15.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 145 | 159 | $23,691 | $3,222 | 13.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 27 | 45 | $32,805 | $2,847 | 8.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 26 | 101 | $17,271 | $2,178 | 12.6% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 19 | 19 | $4,142 | $1,231 | 29.7% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2022 | 16 | 66 | $8,316 | $1,108 | 13.3% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2022 | 21 | 39 | $7,644 | $1,059 | 13.9% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 11 | 11 | $3,201 | $828.17 | 25.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 27 | 27 | $4,617 | $719.28 | 15.6% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2022 | 19 | 19 | $1,159 | $66.29 | 5.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 210 | 298 | $72,116 | $8,445 | 11.7% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2021 | 72 | 114 | $38,988 | $6,279 | 16.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2021 | 182 | 201 | $29,145 | $4,273 | 14.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 38 | 174 | $28,884 | $3,793 | 13.1% |
About Dr. Bin Yang, MD
Dr. Bin Yang, MD is a Anatomic Pathology healthcare provider based in Independence, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003866575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bin Yang, MD has received a total of $184.29 in payments from pharmaceutical and medical device companies, with $23.42 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($184.29).
As a Medicare-enrolled provider, Yang has provided services to 2,427 Medicare beneficiaries, totaling 3,726 services with total Medicare billing of $110,506. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Independence, OH
- Active Since 05/12/2006
- Last Updated 02/01/2008
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1003866575
Products in Payments
- Vemlidy (Drug) $113.55
- ABILIFY MAINTENA (Drug) $47.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.